Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Database of Metabolic Cases and Prevalence of Metabolic Liver Dysfunction (MAFLD/MASLD) in Individuals With Metabolic Syndrome Characteristics - Screening Study (ENDOCARE - SCREEN)

NCT07336563 is registered in ClinicalTrials.gov with Jarosław Drobnik as lead sponsor.

NCT NCT07336563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Database of Metabolic Cases and Prevalence of Metabolic Liver Dysfunction (MAFLD/MASLD) in Individuals With Metabolic Syndrome Characteristics - Screening Study (ENDOCARE - SCREEN)
Lead sponsor
Jarosław Drobnik
Phase
Observational
Overall status
Not yet recruiting
Start date
January 5, 2026
Completion date
October 31, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance syndrome, metabolic dysfunction-associated steatotic liver disease (mash) / nonalcoholic steatohepatitis (nash), metabolic syndrome, obesity & overweight, obesity type 2 diabetes mellitus